Questions about patients' participation in the following clinical trials can be directed to Jane Rabbitt or Margaretta Page by calling 415.353.2966, or by email to Valerie Kivett at kivettv@neurosurg.ucsf.edu.

Adult Clinical Trials: Newly Diagnosed Malignant Glioma
 
A Phase I/II Study of Enzastaurin plus Temozolomide During and Following Radiation Therapy in Patients with Newly Diagnosed Glioblastoma Multiforme and Gliosarcoma
 
A Phase II/III Randomized Study of CDX-110 with Radiation and Temozolomide in Patients with Newly Diagnosed Glioblastoma Multiforme
 
Adult Clinical Trials: Newly Diagnosed Low-Grade Glioma
 
A Phase I Study of Temozolomide (SCH 52365) in the Treatment of Adult Patients with Supratentorial Low-Grade Glioma
 
Adult Clinical Trials: Recurrent Tumor
 
A Phase I Study of Vorinostat (SAHA) and Temozolomide in Patients with Malignant Glioma (NABTC 04-03)
 
Phase I/II Study of OSI-774 (Erlotinib) and CCI-779 (Temsirolimus)in Patients with Recurrent Malignant Glioma (NABTC 04-02)
 
Phase I/II trial of Oncophage (Heat Shock Protein Peptide Complex-96) Vaccine For Patients With Recurrent High Grade Glioma
 
Phase I/II Studies of BAY 43-9006 (sorafenib) in Combination with OSI-774 (erlotinib), R115777 (tipifarnib) or CCI-779 (temsirolimus) in Patients with Recurrent Glioblastoma Multiforme or Gliosarcoma (NABTC05-02)
 
A Phase II study of Bevacizumab plus Temodar and Tarceva after Radiation Therapy and Temodar in Patients with Newly Diagnosed Glioblastoma or Gliosarcoma who are Stable Following Radiation
 
Phase II Study Of 7 Days On/7 Days Off Temozolomide In Patients With High-Grade Glioma
 
Phase II Study of Tarceva in Patients with Recurrent EGFR Positive and PTEN Wild Type Glioblastoma Multiforme and Gliosarcoma
 
Phase II, 2-Part, Multicenter, Open-label Study to Evaluate the Safety, Tolerability, and Efficacy of CT-322 (Angiocept™) Monotherapy and Combination Therapy with Irinotecan in Patients with Recurrent Glioblastoma Multiforme
 
 
Non-Chemotherapy Protocols
 
San Francisco Bay Area Adult Glioma Prognosis Study
 
A Prospective National Study to Molecularly and Genetically Characterize Human Gliomas
 
 
Adult Clinical Trials In Development
 
A Phase 2 Study of XL184 in Subjects with Progressive or Recurrent Glioblastoma Multiforme in First or Second Relapse
 
A Phase I trial of Nanoliposomal CPT-11 (NL CPT-11) in Patients with Recurrent High-Grade Gliomas
 
*Last updated April 29, 2008